138 related articles for article (PubMed ID: 16756084)
1. Synthesis and biological activity of [[(heterocycloamino)alkoxy] benzyl]-2,4-thiazolidinediones as PPARgamma agonists.
Jeon R; Kim YJ; Cheon Y; Ryu JH
Arch Pharm Res; 2006 May; 29(5):394-9. PubMed ID: 16756084
[TBL] [Abstract][Full Text] [Related]
2. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones.
Chhajed SS; Chaskar S; Kshirsagar SK; Haldar GM; Kar Mahapatra D
Comput Biol Chem; 2017 Apr; 67():260-265. PubMed ID: 28193552
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis, and PPARgamma agonistic activity of novel indenone derivatives].
Qu LL; Ma YH
Yao Xue Xue Bao; 2013 Apr; 48(4):508-13. PubMed ID: 23833937
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of potent novel peroxisome proliferator-activated receptor γ indole partial agonists.
Eeda V; Wu D; Lim HY; Wang W
Bioorg Med Chem Lett; 2019 Nov; 29(22):126664. PubMed ID: 31591015
[TBL] [Abstract][Full Text] [Related]
7. Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists.
Hurtevent A; Le Naour M; Leclerc V; Carato P; Melnyk P; Hennuyer N; Staels B; Beucher-Gaudin M; Caignard DH; Dacquet C; Lebegue N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):524-538. PubMed ID: 31939313
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents.
Henry JR; Li Y; Warshawsky AM; Brozinick JT; Hawkins ED; Misener EA; Briere DA; Montrose-Rafizadeh C; Zink RW; Yumibe NP; Ajamie RT; Wilken B; Devanarayan V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6293-7. PubMed ID: 17005393
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and antidiabetic activity of novel tetrahydrocarboline PPAR regulators].
Peng K; Huan Y; Liu Q; Shen ZF; Liu ZZ
Yao Xue Xue Bao; 2014 Apr; 49(4):490-6. PubMed ID: 24974466
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists.
Gim HJ; Li H; Jeong JH; Lee SJ; Sung MK; Song MY; Park BH; Oh SJ; Ryu JH; Jeon R
Bioorg Med Chem; 2015 Jul; 23(13):3322-36. PubMed ID: 25982078
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone.
Seto S; Okada K; Kiyota K; Isogai S; Iwago M; Shinozaki T; Kitamura Y; Kohno Y; Murakami K
J Med Chem; 2010 Jul; 53(13):5012-24. PubMed ID: 20527969
[TBL] [Abstract][Full Text] [Related]
14. In Silico Design, Synthesis and Evaluation of Novel Series of Benzothiazole- Based Pyrazolidinediones as Potent Hypoglycemic Agents.
Haroun M
Med Chem; 2020; 16(6):812-825. PubMed ID: 31880249
[TBL] [Abstract][Full Text] [Related]
15. Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents.
Raval P; Jain M; Goswami A; Basu S; Gite A; Godha A; Pingali H; Raval S; Giri S; Suthar D; Shah M; Patel P
Bioorg Med Chem Lett; 2011 May; 21(10):3103-9. PubMed ID: 21450468
[TBL] [Abstract][Full Text] [Related]
16. In silico design, chemical synthesis and toxicological evaluation of 1,3-thiazolidine-2,4-dione derivatives as PPARγ agonists.
Alemán-González-Duhart D; Tamay-Cach F; Correa-Basurto J; Padilla-Martínez II; Álvarez-Almazán S; Mendieta-Wejebe JE
Regul Toxicol Pharmacol; 2017 Jun; 86():25-32. PubMed ID: 28202347
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
Nazreen S; Alam MS; Hamid H; Yar MS; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai KK
Bioorg Med Chem Lett; 2014 Jul; 24(14):3034-42. PubMed ID: 24890090
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression.
Toyota Y; Nomura S; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2017 Jun; 27(12):2776-2780. PubMed ID: 28465099
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide.
Crosby MB; Svenson JL; Zhang J; Nicol CJ; Gonzalez FJ; Gilkeson GS
J Pharmacol Exp Ther; 2005 Jan; 312(1):69-76. PubMed ID: 15356214
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.
Liu W; Lau F; Liu K; Wood HB; Zhou G; Chen Y; Li Y; Akiyama TE; Castriota G; Einstein M; Wang C; McCann ME; Doebber TW; Wu M; Chang CH; McNamara L; McKeever B; Mosley RT; Berger JP; Meinke PT
J Med Chem; 2011 Dec; 54(24):8541-54. PubMed ID: 22070604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
